D I Zeugolis
Overview
Explore the profile of D I Zeugolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Z, Korntner S, Mullen A, Zeugolis D
Biomater Biosyst
. 2023 Feb;
4:100030.
PMID: 36824570
Collagen type II is the major constituent of cartilage tissue. Yet, cartilage engineering approaches are primarily based on collagen type I devices that are associated with suboptimal functional therapeutic outcomes....
2.
Ryan C, Pugliese E, Shologu N, Gaspar D, Rooney P, Islam M, et al.
Mater Today Bio
. 2021 Oct;
12:100130.
PMID: 34632361
During culture, bereft of their optimal tissue context, tenocytes lose their phenotype and function. Considering that tenocytes in their native tissue milieu are exposed simultaneously to manifold signals, combination approaches...
3.
Helling A, Tsekoura E, Biggs M, Bayon Y, Pandit A, Zeugolis D
ACS Biomater Sci Eng
. 2021 Jan;
3(9):1922-1932.
PMID: 33440550
Matrix metalloproteinase-1 and -8 are active during the wound healing and remodelling processes, degrading native extracellular matrix and implantable devices. However, traditional in vitro assays utilize primarily matrix metalloproteinase-1 to...
4.
Azeem A, Marani L, Fuller K, Spanoudes K, Pandit A, Zeugolis D
ACS Biomater Sci Eng
. 2021 Jan;
3(7):1304-1312.
PMID: 33440519
Biomimetic tissue engineering aspires to develop bioinspired implantable devices that would positively interact with the host. Given that glycosaminoglycans are involved in many physiological processes, whereas their deprivation is associated...
5.
Capella-Monsonis H, Tilbury M, Wall J, Zeugolis D
Mater Today Bio
. 2020 Jun;
7:100057.
PMID: 32577613
The increasing economic burden of wound healing in healthcare systems requires the development of functional therapies. Xenografts with preserved extracellular matrix (ECM) structure and biofunctional components overcome major limitations of...
6.
Graceffa V, Zeugolis D
Eur Cell Mater
. 2019 May;
37:310-332.
PMID: 31038192
The extracellular matrix is a dynamic and active component of the mesenchymal stem cell niche, which controls their differentiation and self-renewal. Traditional in vitro culture systems are not able to...
7.
Irizar A, Amorim M, Fuller K, Zeugolis D, Scott-Fordsmand J
J Mater Sci Mater Med
. 2018 May;
29(5):51.
PMID: 29713809
Poly-ε-caprolactone (PCL) based medical devices are increasingly produced and thus, their presence in the environment is likely to increase. The present study analysed the biodegradation of PCL electro-spun scaffolds (alone)...
8.
Tsekoura E, Helling A, Wall J, Bayon Y, Zeugolis D
Biomed Mater
. 2017 Jun;
12(3):035013.
PMID: 28628484
Implant infections remain a major healthcare problem due to the prolonged hospitalisation period required to disrupt and treat bacterial biofilm formation, and the need for additional surgery to remove/replace the...
9.
Bayon Y, Bohner M, Eglin D, Procter P, Richards R, Weber J, et al.
J Mater Sci Mater Med
. 2016 Aug;
27(9):144.
PMID: 27552808
The European Society for Biomaterials 2015 Translational Research Symposium focused on 'Innovating in the Medical Device Industry - Challenges & Opportunities' from different perspectives, i.e., from a non-profit research organisation...
10.
Sanami M, Shtein Z, Sweeney I, Sorushanova A, Rivkin A, Miraftab M, et al.
Biomed Mater
. 2015 Nov;
10(6):065005.
PMID: 26541078
Collagen type I, in various physical forms, is widely used in tissue engineering and regenerative medicine. To control the mechanical properties and biodegradability of collagen-based devices, exogenous cross-links are introduced...